4//SEC Filing
Hirsch Douglas Joseph 4
Accession 0001809519-24-000173
CIK 0001809519other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:05 PM ET
Size
15.7 KB
Accession
0001809519-24-000173
Insider Transaction Report
Form 4
Hirsch Douglas Joseph
Director
Transactions
- Conversion
Class A Common Stock
2024-09-01+126,552→ 126,552 total - Tax Payment
Class B Common Stock
2024-09-01$7.90/sh−130,043$1,027,340→ 126,552 total→ Class A Common Stock (130,043 underlying) - Conversion
Class B Common Stock
2024-09-01−126,552→ 0 total→ Class A Common Stock (126,552 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-09-01−256,595→ 0 total→ Class B Common Stock (256,595 underlying) - Exercise/Conversion
Class B Common Stock
2024-09-01+256,595→ 256,595 total→ Class A Common Stock (256,595 underlying)
Holdings
- 2,632,721(indirect: By DH 2024 GRAT)
Class A Common Stock
- 2,632,721(indirect: By CH 2024 GRAT)
Class A Common Stock
Footnotes (5)
- [F1]Share held directly by DH 2024 GRAT, a grantor retained annuity trust (the "DH 2024 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024 GRAT.
- [F2]Share held directly by CH 2024 GRAT, a grantor retained annuity trust (the "CH 2024 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Class B common stock.
- [F4]The restricted stock units vested or will vest in 16 equal quarterly installments that commenced on September 1, 2020.
- [F5]Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001822522
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:05 PM ET
- Size
- 15.7 KB